InSilicoTrials and Galileo Research announce their partnership
Innovation and cutting-edge technology to reduce Research and Development time and costs: InSilicoTrials, a company...
Velocity Clinical Research’s multi-site acquisitions signal new frontier for clinical site management industry
Velocity Clinical Research announces it has acquired two multi-site companies, VitaLink Research and the National...
FDA Approves Samsung Bioepis and Biogens BYOOVIZ, LUCENTIS Biosimilar
Samsung Bioepis Co., Ltd. and Biogen Inc. announced that the U.S. FDA has approved BYOOVIZ...
Biocon Biologics and Serum Institute Life Sciences Announce Strategic Alliance
Biocon Biologics Limited (BBL), a subsidiary of Biocon Ltd. and Serum Institute Life Sciences Private...
Frontage Expands Early Drug Discovery Services through the Acquisition of Heyan Biotech
Frontage Shanghai announced the acquisition of 70% equity interest in Wuhan Heyan Biomedical Technology Co.,...
Recro and BioCorRx expand partnership for OUD treatment
Recro Pharma, Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation...
Repligen and Navigo GmbH Announce Launch of Industry First Protein A Ligand for Purification...
Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, and Navigo Proteins GmbH...
GeneQuine Selects Exothera to Support the Next Stage of Its Osteoarthritis Gene Therapy Development
GeneQuine Biotherapeutics GmbH, a biotech company focused on the development of gene therapy for musculoskeletal...
Boehringer Ingelheim and Twist Bioscience Enter Therapeutic Antibody Discovery Collaboration
Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic...
Exscientia enters $70M collaboration to develop anti-viral therapeutics against Coronavirus and other viruses with...
Exscientia, an AI-driven pharmatech company with a mission to radically improve how drugs are discovered,...
